Glatiramer Acetate NDC 82983-430

NDC codes

FDA NDC Directory

Product NDC (as listed)82983-430Labeler and product segments. Claims need a package NDC.

Product NDC at billing width82983-0430Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
82983-430-12	82983043012	12 BLISTER PACK in 1 CARTON (82983-430-12) / 1 SYRINGE in 1 BLISTER PACK (82983-430-01) / 1 mL in 1 SYRINGEMarketed from Mar 20, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Glatiramer Acetate
Generic name (nonproprietary): glatiramer acetate
Active ingredients: Glatiramer acetate — 40 mg/mL
Dosage form: Injection, Solution
Route: Subcutaneous
Labeler: AJENAT PHARMACEUTICALS LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214022
Marketing start: Mar 20, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 82983-430_ec371b5b-1ec4-4eaa-8f5e-2c06f5965a2eSPL ID ec371b5b-1ec4-4eaa-8f5e-2c06f5965a2eSPL set ID 1ec10223-880d-402f-a759-9cd179bf09deRxCUI 1487361UNII 5M691HL4BOUPC 0382983430129, 0382983430013

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N482983043012 followed by a unit qualifier and the quantity

Package 82983-0430-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 10, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)